↑↓ navigate open esc close
Portugal BASE contract award · ocds-ted-252421-2025

Portugal – Pharmaceutical products – aquisição do medicamento Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr

Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. awarded €1.5M to Imprensa Nacional-Casa da Moeda, S. A. (INCM) for Construction & Public Works in April 2025 — one of 76 awards this buyer has made, above its typical award size.

17 Apr 2025
Award date
€1.5M
Contract value
76 Awards
€9.9M Avg award
Above vs typical
93 Awards
36 Buyers
€807M Total won

Contract description

Portugal – Pharmaceutical products – aquisição do medicamento Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV

Premium

Related awards · Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E.

76 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

32 more awards from this buyer · full history & CSV export

Premium

Other wins · Imprensa Nacional-Casa da Moeda, S. A. (INCM)

93 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. and Imprensa Nacional-Casa da Moeda, S. A. (INCM) — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up